Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine

BACKGROUND: The United States Food and Drug Administration (FDA) monitors, inspects, and enforces the promotion of products by companies that claim to mitigate, prevent, treat, diagnose, or cure COVID-19. The introduction of COVID-19-related diagnostics and therapeutics during the pandemic has highl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Allan, Sheikhan, Natasha Y., Sheikhan, Tania, Nowak, Dominik A., Witek, Theodore J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Brief Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651501/
https://www.ncbi.nlm.nih.gov/pubmed/34876238
http://dx.doi.org/10.1186/s42238-021-00109-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651501/
https://www.ncbi.nlm.nih.gov/pubmed/34876238
http://dx.doi.org/10.1186/s42238-021-00109-6

Ejemplares similares